Revisiting the Pathogenesis of Rheumatic Fever and Carditis
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Myocarditis and Cardiomyopathy
CE: Tripti; HCO/330310; Total nos of Pages: 6; HCO 330310 REVIEW CURRENT OPINION Myocarditis and cardiomyopathy Jonathan Buggey and Chantal A. ElAmm Purpose of review The aim of this study is to summarize the literature describing the pathogenesis, diagnosis and management of cardiomyopathy related to myocarditis. Recent findings Myocarditis has a variety of causes and a heterogeneous clinical presentation with potentially life- threatening complications. About one-third of patients will develop a dilated cardiomyopathy and the pathogenesis is a multiphase, mutlicompartment process that involves immune activation, including innate immune system triggered proinflammatory cytokines and autoantibodies. In recent years, diagnosis has been aided by advancements in cardiac MRI, and in particular T1 and T2 mapping sequences. In certain clinical situations, endomyocardial biopsy (EMB) should be performed, with consideration of left ventricular sampling, for an accurate diagnosis that may aid treatment and prognostication. Summary Although overall myocarditis accounts for a minority of cardiomyopathy and heart failure presentations, the clinical presentation is variable and the pathophysiology of myocardial damage is unique. Cardiac MRI has significantly improved diagnostic abilities, but endomyocardial biopsy remains the gold standard. However, current treatment strategies are still focused on routine heart failure pharmacotherapies and supportive care or cardiac transplantation/mechanical support for those with end-stage heart failure. Keywords cardiac MRI, cardiomyopathy, endomyocardial biopsy, myocarditis INTRODUCTION prevalence seen in children and young adults aged Myocarditis refers to inflammation of the myocar- 20–30 years [1]. dium and may be caused by infectious agents, systemic diseases, drugs and toxins, with viral infec- CAUSE tions remaining the most common cause in the developed countries [1]. -
Myocarditis, Pericarditis and Other Pericardial Diseases
Heart 2000;84:449–454 Diagnosis is easiest during epidemics of cox- GENERAL CARDIOLOGY sackie infections but diYcult in isolated cases. Heart: first published as 10.1136/heart.84.4.449 on 1 October 2000. Downloaded from These are not seen by cardiologists unless they develop arrhythmia, collapse or suVer chest Myocarditis, pericarditis and other pain, the majority being dealt with in the primary care system. pericardial diseases Acute onset of chest pain is usual and may mimic myocardial infarction or be associated 449 Celia M Oakley with pericarditis. Arrhythmias or conduction Imperial College School of Medicine, Hammersmith Hospital, disturbances may be life threatening despite London, UK only mild focal injury, whereas more wide- spread inflammation is necessary before car- diac dysfunction is suYcient to cause symp- his article discusses the diagnosis and toms. management of myocarditis and peri- Tcarditis (both acute and recurrent), as Investigations well as other pericardial diseases. The ECG may show sinus tachycardia, focal or generalised abnormality, ST segment eleva- tion, fascicular blocks or atrioventricular con- Myocarditis duction disturbances. Although the ECG abnormalities are non-specific, the ECG has Myocarditis is the term used to indicate acute the virtue of drawing attention to the heart and infective, toxic or autoimmune inflammation of leading to echocardiographic and other investi- the heart. Reversible toxic myocarditis occurs gations. Echocardiography may reveal segmen- in diphtheria and sometimes in infective endo- -
Heart Pathology in Rheumatic Heart Disease
University of Nebraska Medical Center DigitalCommons@UNMC MD Theses Special Collections 5-1-1941 Heart pathology in rheumatic heart disease Jacob J. Brenneman University of Nebraska Medical Center This manuscript is historical in nature and may not reflect current medical research and practice. Search PubMed for current research. Follow this and additional works at: https://digitalcommons.unmc.edu/mdtheses Part of the Medical Education Commons Recommended Citation Brenneman, Jacob J., "Heart pathology in rheumatic heart disease" (1941). MD Theses. 846. https://digitalcommons.unmc.edu/mdtheses/846 This Thesis is brought to you for free and open access by the Special Collections at DigitalCommons@UNMC. It has been accepted for inclusion in MD Theses by an authorized administrator of DigitalCommons@UNMC. For more information, please contact [email protected]. HEART PATHOLOGY IN RHEUMATIC HEART DISEASE J. James Brenneman Senior Thesis The College ot Medicine University of Nebraska Omaha, Nebraska CONTENTS Definition ............................ Page 1 Introduction and History .............. 2 General Pathology . ..... g The Typical Lesion -- The Aschoff Body 17 Specific Lesions - ·········~·~,~···· 25 Myocardial . .......... 25 Endocardial and Valvular .. 32 Per1cardial ................ 37 Conduction Mechanism ........ 4-2 s~~mary and Conclusion~ . ............ 52 481211 1. DEFINITION Cecil, (1). "Rheumatic fever is a disease, orobably infectious, and apparently closely associated with invasion of the body by hemolytic streptococci; it is characterized by febrile and toxic states7 by the presence in various parts or the cardiovascular system and joints or multiple disseminated focal inflammatory lesions and at times by serof1brinous inflammation or some or the great mesothe11al lined body cavities and joints; it is further characterized by a tendency for the febrile, toxio and arthritic signs to disappear following the exhibition of certain antipyretio drugs in sufficient doses." 2. -
Rheumatic Fever and Rheumatic Heart Disease
SEVENTY-FIRST WORLD HEALTH ASSEMBLY A71/25 Provisional agenda item 12.8 12 April 2018 Rheumatic fever and rheumatic heart disease Report by the Director-General 1. In May 2017, the Executive Board, at its 141st session, noted an earlier version of this report1 and adopted resolution EB141.R1 on rheumatic fever and rheumatic heart disease. Paragraphs 15 and 18 in this report contain new text in response to comments from Member States. WHERE DO WE STAND TODAY? 2. Rheumatic heart disease is a preventable yet serious public health problem in low- and middle-income countries and in marginalized communities in high-income countries, including indigenous populations. 3. The disease results from damage to heart valves caused by one or several episodes of rheumatic fever, an autoimmune inflammatory reaction to throat infection caused by group A streptococci (streptococcal pharyngitis). It most commonly occurs in childhood, and can lead to death or life-long disability. Effective early intervention can prevent premature mortality from rheumatic heart disease. 4. Some 30 million people are currently thought to be affected by rheumatic heart disease globally,2 and in 2015 rheumatic heart disease was estimated to have been responsible for 305 000 deaths and 11.5 million disability-adjusted life years lost. Of these deaths 60% occurred prematurely (that is, before the age of 70 years), although these figures are very uncertain owing to incomplete data in many countries. Despite the availability of effective measures for prevention and treatment, there has been little change in the contribution of rheumatic heart disease to overall global mortality between 2000 and 2015.3 5. -
Valvular Heart Disease Acute Rheumatic Fever
Valvular heart disease Acute rheumatic fever Rheumatic fever • It typically occurs several weeks after streptococcal pharyngitis. • The most common pathogen is group A beta-hemolytic streptococci (GABHS) • Streptococcus cross-react with proteins in cardiac valves. • Time from acute streptococcal infection to onset of symptomatic rheumatic fever (RF) is usually 3–4 weeks. • RF is thought to complicate up to 3% of untreated streptococcal sore throats. • Previous episodes of RF predispose to recurrences. Diagnostic criteria for rheumatic fever (Jones criteria) • Evidence of group A streptococcal pharyngitis • Either a positive throat culture or rapid streptococcal antigen test, or an elevated or rising streptococcal antibody titer (samples taken 2 weeks apart). • Plus two major or one major and two minor Jones criteria: Major criteria Minor criteria • Polyarthritis • Fever • Carditis • Arthralgia • Chorea • Prolonged PR interval • Erythema marginatum • Elevated ESR and CRP • Subcutaneous nodules Joints • Migratory large-joint polyarthritis starting in the lower limbs in 75% of cases. Duration is <4 weeks at each site. There is severe pain and tenderness in contrast to a mild degree of joint swelling. Heart • Pancarditis occurs in 50% of cases with features of acute heart failure, mitral and aortic regurgitation, and pericarditis. • Endocarditis • affects the mitral valve (65%–70%), aortic valve (25%), and tricuspid valve (10%, never in isolation), causing acute regurgitation and heart failure but chronic stenosis. • Pericarditis • Pain • Friction rub • rarely causes hemodynamic instability/tamponade or constriction. Heart Myocarditis • Acute heart failure • Arrhythmias • Most common reason of death Skin • Erythema marginatum is an evanescent rash with serpiginous outlines and central clearings on the trunk and proximal limbs. -
Rheumatic Fever and Rheumatic Heart Disease in Children Below the Age of 5 Years in the Tropics
Ann Rheum Dis: first published as 10.1136/ard.24.4.389 on 1 July 1965. Downloaded from Ann. rheumn. Dis. (1965). 24, 389. RHEUMATIC FEVER AND RHEUMATIC HEART DISEASE IN CHILDREN BELOW THE AGE OF 5 YEARS IN THE TROPICS BY ZAHIRA H. ABDIN AND A. EISSA From the Rheumatic and Heart Unit, Children's Hospital, Cairo University, Egypt Rheumatic fever and particularly rheumatic heart months. The history and main clinical finding in disease have always been regarded as rare conditions these four cases is given in the footnote below.* below the age of 5 years and as very rare below 3 years The sex distribution was 42 females to 26 males, (Holt and McIntosh, 1953). Reported cases are i.e. 2-4:1 compared to a general incidence of 1 7:1 few and no account of the clinical pattern of the (Table I). disease in the small child has been found in the TABLE I literature. SEX RATIO AND FAMILIAL TENDENCY In the Rheumatic and Heart Clinic, in Cairo Rto Positive Familial University Hospital, we have had the opportunity Group No. of Sex Ratio History* of examining large numbers of children referred with Cases Female:Male (per cent.) rheumatic fever and rheumatic heart disease in the 1. Children below 5 last 4 years. It was thus possible to collect a fairly years .. 68 2-4:1 20-5 copyright. large group of younger children with the disease and II. Children of all ages 1.7:11,000 3 - 5 we were able to examine the incidence as well as the special features of rheumatic fever and rheumatic * X2 82-5. -
Currentstateofknowledgeonaetiol
European Heart Journal (2013) 34, 2636–2648 ESC REPORT doi:10.1093/eurheartj/eht210 Current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases Downloaded from Alida L. P. Caforio1†*, Sabine Pankuweit2†, Eloisa Arbustini3, Cristina Basso4, Juan Gimeno-Blanes5,StephanB.Felix6,MichaelFu7,TiinaHelio¨ 8, Stephane Heymans9, http://eurheartj.oxfordjournals.org/ Roland Jahns10,KarinKlingel11, Ales Linhart12, Bernhard Maisch2, William McKenna13, Jens Mogensen14, Yigal M. Pinto15,ArsenRistic16, Heinz-Peter Schultheiss17, Hubert Seggewiss18, Luigi Tavazzi19,GaetanoThiene4,AliYilmaz20, Philippe Charron21,andPerryM.Elliott13 1Division of Cardiology, Department of Cardiological Thoracic and Vascular Sciences, University of Padua, Padova, Italy; 2Universita¨tsklinikum Gießen und Marburg GmbH, Standort Marburg, Klinik fu¨r Kardiologie, Marburg, Germany; 3Academic Hospital IRCCS Foundation Policlinico, San Matteo, Pavia, Italy; 4Cardiovascular Pathology, Department of Cardiological Thoracic and Vascular Sciences, University of Padua, Padova, Italy; 5Servicio de Cardiologia, Hospital U. Virgen de Arrixaca Ctra. Murcia-Cartagena s/n, El Palmar, Spain; 6Medizinische Klinik B, University of Greifswald, Greifswald, Germany; 7Department of Medicine, Heart Failure Unit, Sahlgrenska Hospital, University of Go¨teborg, Go¨teborg, Sweden; 8Division of Cardiology, Helsinki University Central Hospital, Heart & Lung Centre, -
Neuropsychiatric Manifestations of Infective Endocarditis: a Study of 95 Patients at Ibadan, Nigeria
J Neurol Neurosurg Psychiatry: first published as 10.1136/jnnp.39.4.325 on 1 April 1976. Downloaded from Journal of Neurology, Neurosurgery, and Psychiatry, 1976, 39, 325-329 Neuropsychiatric manifestations of infective endocarditis: a study of 95 patients at Ibadan, Nigeria 0. BADEMOSI,1 A. 0. FALASE, F. JAIYESIMI, AND A. BADEMOSI From the Departments of Medicine and Paediatrics, University College Hospital, Ibadan, Nigeria SYNOPSIS Thirty-eight percent of patients with infective endocarditis (36 of 95) had neuropsychi- atric manifestations. In 750 (27 of 36), these features were the major presenting picture. Fifteen patients (42%) presented with cerebrovascular lesions and seven (19%) with meningitis. Toxic encephalopathy (12.5%) was not uncommon. Other neurological syndromes seen included psychosis and spinal cord lesions. The mortality was high especially when the infective endocarditis was acute in onset. It is essential to search diligently for an underlying cardiac cause in patients who present with neuropsychiatric symptoms because treatment of the underlying pathology improves prognosis. Although the clinical features of infective endo- criteria: (1) repeated positive blood cultures during a Protected by copyright. carditis are well established, significant changes febrile illness in a patient with known previous have taken place in the pattern of the disease in valvular or congenital heart disease; (2) evidence of the developed countries over the last 20 years peripheral manifestations of infective endocarditis; 1951; Pankey, (3) development of a significant cardiac murmur (Horder, 1909; Cates and Christie, with features of cardiac failure in any patient 1961, 1962; Thompson, 1964; Cooper et al., admitted for an unexplained febrile illness while 1966; British Medical Journal, 1973). -
Rheumatic Carditis Treated with High Doses of Pulsetherapy Methylprednisolone
Herdy et al OriginalArq Bras Article Cardiol Rheumatic carditis treated with metilprednisolone volume 72, (nº 5), 1999 Rheumatic Carditis Treated with High Doses of Pulsetherapy Methylprednisolone. Results in 70 Children Over 12 Years Gesmar Volga Haddad Herdy, Carlos Alberto Pinto, Maria Cecilia Olivaes, Elisabeth Amabile Carvalho, Hsu Tchou, Raquel Cosendey, Raquel Ribeiro, Fabiano Azeredo, Debora de Souza, Artur H. Herdy, Vania Glória S. Lopes Niterói, RJ - Brazil Purpose - To report the result of patients treated with Data from the World Health Organization reveal that IV methylprednisolone divided into three groups and 3% of the children experiencing infection of the upper compare their follow-up during the last 12 years. respiratory tract by group A β-hemolytic streptococci develop rheumatic fever, of whom, 30% have carditis 1. 30% Methods - Seventy children with active rheumatic to 70% of the patients with rheumatic sequelae do not carditis (76 episodes) in heart failure Class III and IV report previous oropharynx infection 2,3. Some of these (NYHA) were studied. The diagnosis was based on modi- children of preschool age might have severe congestive fied Jones’ criteria. After ruling out infections and stron- heart failure (CHF) due to severe carditis and rupture of gyloidiasis, treatment with IV methylprednisolone bolus mitral chordae tendineae, as already previously reported 4. was started three times a week until the laboratory tests In such cases, treatment with intravenous methylpre- became negative. Patients were divided into 3 groups, dnisolone proved efficient 5,6. This study aims to report the according to the time of hospital admittance: Groups 1, 2 and 3, comprising of 40, 18 and 12 children, respectively. -
Lyme Carditis and Sudden Cardiac Death
Health Update August 6, 2018 TO: Health Care Providers FROM: Mark Levine, MD, Commissioner of Health Lyme Carditis and Sudden CardiaC Death – Please Distribute as Appropriate – Laboratory results from the Centers for Disease Control and Prevention (CDC) have confirmed that the recent death of a Franklin County resident was a result of Lyme carditis, a rare complication of Lyme disease. This is the first reported death due to Lyme carditis in Vermont. Between 1985 and 2014 there were nine deaths related to Lyme carditis reported worldwide. The Health Department issued a Health Advisory on December 13, 2013 following a CDC report about sudden cardiac death associated with Lyme carditis. Symptomatic infection of the heart is rare in recognized Lyme disease cases. Approximately 1 percent of reported cases have Lyme carditis, which is usually present with other features of Lyme disease but can be observed independently. It is more common among males than would be expected based on the gender distribution of patients with clinical manifestations of Lyme disease. • Vermont Health Advisory: http://www.healthvermont.gov/dec2013_healthadvisory • CDC report: http://www.cdc.gov/mmwr/preview/mmwrhtml/mm6249a1.htm?s_cid=mm6249a1_w The most common cardiac manifestation is atrioventricular block (first, second, or third degree). Symptoms of atrioventricular block include lightheadedness, palpitations, shortness of breath, chest pain and syncope. Some cases might require temporary pacing, although prognosis is excellent with appropriate antibiotic therapy. Lyme disease is endemic in Vermont. Place carditis symptoms in context during the spring, summer and fall seasons. Actions Requested: • If you suspect Lyme disease, treat with antibiotics according to current treatment guidelines: https://www.cdc.gov/lyme/treatment/index.html • Ask all patients with suspected Lyme disease about cardiac symptoms. -
Acute Rheumatic Fever and Rheumatic Heart Disease in Resource-Limited Settings
Downloaded from http://adc.bmj.com/ on April 28, 2017 - Published by group.bmj.com Global child health Acute rheumatic fever and rheumatic heart disease in resource-limited settings Gabriella Watson,1 Bintou Jallow,1 Kirsty Le Doare,1,2 Kuberan Pushparajah,3 Suzanne T Anderson1 ▸ Additional material is ABSTRACT working in resource-limited settings in their diag- published online only. To view Poststreptococcal complications, such as acute rheumatic nosis and management, and approaches for over- please visit the journal online fi (http://dx.doi.org/10.1136/ fever (ARF) and rheumatic heart disease (RHD), are coming some of these dif culties. archdischild-2014-307938). common in resource-limited settings, with RHD recognised as the most common cause of paediatric ACUTE RHEUMATIC FEVER 1Gambia Unit, Medical Research Council, Fajara, heart disease worldwide. Managing these conditions in Case vignette The Gambia resource-limited settings can be challenging. We review A 12-year-old Gambian girl presented to a health 2Wellcome Centre for Global the investigation and treatment options for ARF and centre complaining of lethargy, arthralgia and inter- Health Research, Imperial RHD and, most importantly, prevention methods in an mittent fever. She was diagnosed with clinical College, London, UK 3Department of Congenital African setting. malaria and treated accordingly. Heart Disease, Evelina London Four months later she presented to clinic with Children’s Hospital, Guy’s&St similar symptoms. On examination she looked Thomas’ NHS Foundation INTRODUCTION acutely unwell with a soft systolic murmur in the Trust, London, UK Infections caused by Group A streptococcus (GAS) mitral area. Blood tests showed leukocytosis and a fi Correspondence to were identi ed as the ninth leading cause of global raised erythrocyte sedimentation rate (ESR) of Dr Gabriella Watson, Gambia mortality from an individual pathogen in the 2004 130 mm/h. -
Rheumatic Heart Disease
put together by Alex Yartsev: Sorry if i used your images or data and forgot to reference you. Tell me who you are. [email protected] Rheumatic Heart Disease History of Presenting Illness - Dyspnoea on exertion or at rest - Nocturnal dyspnoea - Orthopnoea - Swollen ankles4 - “mitral facies” - Palpitations - Chest pain Differential Diagnoses Aortic Stenosis, Valvar Human Immunodeficiency Virus Infection Aortic Valve Insufficiency Kawasaki Disease Aortic Valve, Bicuspid Mitral Stenosis, Congenital Appendicitis Mitral Valve Insufficiency Arthritis, Septic Mitral Valve Prolapse Cardiac Tumors Myocarditis, Viral Cardiomyopathy, Dilated Pericardial Effusion, Malignant Carnitine Deficiency Pericarditis, Bacterial Coccidioidomycosis Pericarditis, Viral Endocarditis, Bacterial Sarcoidosis Heart Failure, Congestive Systemic Lupus Erythematosus Histoplasmosis Transient Synovitis How is this diagnosis made? The Jones criteria require the presence of 2 major or 1 major and 2 minor criteria major diagnostic criteria minor diagnostic criteria - Carditis - fever - Polyarthritis - arthralgia - Chorea - prolonged PR interval on ECG - subcutaneous nodules - elevated ESR or CRP - erythema marginatum - leukocytosis Additional evidence of previous group A streptococcal pharyngitis is required - Positive throat culture or rapid streptococcal antigen test - Elevated or rising streptococcal antibody titer - History of previous rheumatic fever or rheumatic heart disease Pertinent Findings on History - PAST HISTORY OF RHEUMATIC HEART DISEASE: most important. - CHILDHOOD STREP THROAT: school age (peak 5-15years) Findings on Examination CARDIAC MANIFESTATIONS: Rapid irregular pulse!! AF - Pancarditis is the most serious and second most common complication of rheumatic fever (50%). In advanced cases, patients may complain of dyspnea, mild-to-moderate chest discomfort, pleuritic chest pain, edema, cough, or orthopnea. - carditis is most commonly detected by a new murmur and tachycardia out of proportion to fever.